tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RLMD Stock Latest News

Relmada Therapeutics CMO Purchases 55,000 Shares
Company AnnouncementsRelmada Therapeutics CMO Purchases 55,000 Shares
6d ago
8K
RLMD
Relmada Therapeutics’ Earnings Call Highlights Positive Momentum
PremiumCompany Announcements
Relmada Therapeutics’ Earnings Call Highlights Positive Momentum
26d ago
RLMD
Relmada Therapeutics Reports Promising Trial Results
PremiumCompany Announcements
Relmada Therapeutics Reports Promising Trial Results
1M ago
RLMD
Relmada Therapeutics Reports Promising Phase 2 Study Results
PremiumCompany Announcements
Relmada Therapeutics Reports Promising Phase 2 Study Results
1M ago
8K
RLMD
Relmada Therapeutics Granted Nasdaq Listing Extension
PremiumCompany Announcements
Relmada Therapeutics Granted Nasdaq Listing Extension
2M ago
8K
RLMD
Relmada Therapeutics appoints Lotan to Chair of Clinical Advisory Board
PremiumThe FlyRelmada Therapeutics appoints Lotan to Chair of Clinical Advisory Board
2M ago
RLMD
Relmada Therapeutics Ends Esmethadone License Agreement
Premium
Company Announcements
Relmada Therapeutics Ends Esmethadone License Agreement
2M ago
8K
RLMD
Relmada Therapeutics Appoints New Chief Medical Officer
Premium
Company Announcements
Relmada Therapeutics Appoints New Chief Medical Officer
3M ago
8K
RLMD
Relmada Therapeutics appoints Raj Pruthi as CMO, Urology
PremiumThe Fly
Relmada Therapeutics appoints Raj Pruthi as CMO, Urology
3M ago
RLMD
Relmada Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
Relmada Therapeutics Holds Annual Stockholders Meeting
3M ago
8K
RLMD
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
TIL
IMNN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
CVM
TIL
Relmada Therapeutics’ Earnings Call: Promising Data Amid Financial Concerns
PremiumCompany AnnouncementsRelmada Therapeutics’ Earnings Call: Promising Data Amid Financial Concerns
4M ago
RLMD
VA secretary wants to find answers on psychedelics therapies, Politico says
Premium
The Fly
VA secretary wants to find answers on psychedelics therapies, Politico says
4M ago
ATAI
CYBN
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
Premium
The Fly
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
4M ago
TMO
ATAI
Relmada Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Relmada Therapeutics Reports Q1 2025 Financial Results
4M ago
RLMD
Relmada Therapeutics Announces Positive Phase 2 Study Results
PremiumCompany Announcements
Relmada Therapeutics Announces Positive Phase 2 Study Results
4M ago
8K
RLMD
Relmada Therapeutics presents initial Phase 2 NDV-01 data at AUA2025
PremiumThe Fly
Relmada Therapeutics presents initial Phase 2 NDV-01 data at AUA2025
4M ago
RLMD
Relmada Therapeutics to hold a virtual meeting
PremiumThe Fly
Relmada Therapeutics to hold a virtual meeting
4M ago
RLMD
Relmada Therapeutics: Hold Rating Amid Uncertainty and Strategic Shifts
PremiumRatingsRelmada Therapeutics: Hold Rating Amid Uncertainty and Strategic Shifts
5M ago
RLMD
Relmada Therapeutics: Strategic Acquisitions and Pipeline Progress
Premium
Company Announcements
Relmada Therapeutics: Strategic Acquisitions and Pipeline Progress
5M ago
RLMD
Relmada Therapeutics Reports 2024 Financial Results and Strategic Progress
Premium
Company Announcements
Relmada Therapeutics Reports 2024 Financial Results and Strategic Progress
5M ago
RLMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >